A detailed history of Core Cap Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 146 shares of EMBC stock, worth $2,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146
Previous 146 -0.0%
Holding current value
$2,960
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$10.13 - $14.6 $1,478 - $2,131
146 New
146 $1,000
Q1 2024

Aug 08, 2024

BUY
$12.35 - $19.33 $308 - $483
25 Added 17.12%
171 $2,000
Q4 2022

Feb 10, 2023

BUY
$25.29 - $35.48 $4,678 - $6,563
185 New
185 $4,000
Q2 2022

Aug 11, 2022

BUY
$24.78 - $33.36 $6,343 - $8,540
256 New
256 $6,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.